Decipher FDA's New Med Safety in Pregnancy Rating System

October 2018

Patients rely on you for the bottom line on med safety in pregnancy.

An FDA rule eliminated the letter categories...A, B, C, D, and X...for meds approved since July 2015. Older meds must remove them by 2020.

The old categories were oversimplified and often misinterpreted.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Influenza Emphasize Influenza Immunization for 2018-19
Epinephrine Be Ready for Questions About EpiPen Shortages and Generics
Cardiology Address Depression in Patients After a Heart Attack
Generics Prepare for Generic Tadalafil and Vardenafil
Pharmacogenetics Put Pharmacogenetic Testing for Mental Health Meds in Perspective
Natural Medicines Focus on Safety if Patients Use Essential Oils
Antipsychotics Compare Aristada Initio and Perseris to Other Injectable Antipsychotics
Dermatology Help Get to the Bottom of Diaper Rash
Endometriosis Watch for Orilissa, a New Med for Endometriosis
Pregnancy Decipher FDA's New Med Safety in Pregnancy Rating System
HIV & AIDS Expect Integrase Inhibitors to Gain an Edge in Treating HIV
Medicare Answer Questions About 2019 Medicare Part D Changes
Practice Remember "Cooler Heads Prevail" When Conflict Arises